Glycoprotein analysis for the diagnostic evaluation of platelet disorders

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 2, 2009, Pages 224-232

  Miller, Jonathan L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Platelet glycoproteins; Platelet membrane disorders; Platelets

Indexed keywords

ALPHA2 INTEGRIN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN 1B BETA; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN VI; THROMBIN RECEPTOR; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; UROKINASE; VERY LATE ACTIVATION ANTIGEN 2;

BERNARD SOULIER DISEASE; DIAGNOSTIC VALUE; FANCONI ANEMIA; FLOW CYTOMETRY; GLANZMANN DISEASE; GRAY THROMBOCYTE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUEBEC PLATELET DISORDER; REVIEW; THROMBOCYTE DISORDER; WESTERN BLOTTING; BLOOD; CHEMISTRY; GENETICS; THROMBOCYTE;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; GLYCOPROTEINS; HUMANS;

EID: 69249215479     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1220330     Document Type: Review

References (56)

1. Nurden AT, Nurden P. Inherited disorders of platelets: an update. Curr Opin Hematol 2006;13:157-162
2. Coller BS, Shattil SJ. The GPIIb/IIIa (integrin alphaIIb-beta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 2008;112:3011-3025
3. Caen JP, Nurden AT, Jeanneau C, et al. Bernard-Soulier syndrome. A new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med 1976;87:586-596
4. Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975;255:720-722
5. Phillips DR, Agin PP. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977;60:535-545
6. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979;64:1393-1401
7. Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978;52:453-466
8. McGregor JL, Clezardin P, James E, McGregor L, Dechavanne M, Clemetson KJ. Identification and characterization of fragments of major glycoproteins from platelet membrane after chymotrypsin treatment. Eur J Biochem 1985;148:97-106 (Pubitemid 15081003)
9. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986;261:12579-12585 (Pubitemid 17204209)
10. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr- 276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin. Biochemistry 1996;35:4929-4938
11. Kunicki TJ, Nurden AT, Pidard D, Russell NR, Caen JP. Characterization of human platelet glycoprotein antigens giving rise to individual immunoprecipitates in crossedimmunoelectrophoresis. Blood 1981;58:1190-1197 (Pubitemid 12251147)
12. Karpatkin S, Shulman S, Howard L. Crossed immunoelectrophoresis of human platelet membranes. Methods Enzymol 1992;215:440-455
13. Fabris F, Cordiano I, Mazzuccato M, Pradella P, Randi MLG. Labeling of platelet surface glycoproteins with biotin derivatives. Thromb Res 1992;66:409-419
14. Gibbins JM. Techniques for analysis of proteins by SDS-polyacrylamide gel electrophoresis and Western blotting. Methods Mol Biol 2004;273:139-152
15. Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006;35:67-82
16. Michelson AD, Linden MD, Barnard MR, Furman MI, Frelinger A L III. Flow cytometry. In: Michelson AD, ed. Platelets. 2nd ed. New York, NY: Elsevier; 2007:545-564
17. Rand ML, Leung R, Packham MA. Platelet function assays. Transfus Apher Sci 2003;28:307-317
18. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Semin Thromb Hemost 2007;33:771-779 (Pubitemid 351158445)
19. Israels S. Diagnostic evaluation of platelet function disorders in neonates and children: an update. Semin Thromb Hemost 2009;35:181-188
20. Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009;35:189-203
21. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009;35:158-167
22. McGlasson D, Fritsma G. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 2009;35:168-180
23. Nurden A, Fiore M, Pillois X, Nurden P. Genetic testing in the diagnostic evaluation of inherited platelet disorders. Semin Thromb Hemost 2009;35:204-212
24. Weiss H. Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin Thromb Hemost 2009;35:233-241
25. Glanzmann Thombasthenia Database. Mount Sinai School of Medicine, Department ofMedicine. 2008; Available at: http://www.sinaicentral.mssm.edu/ intranet/research/glanzmann. Accessed January 28, 2009
26. Kiyoi T, Tomiyama Y, Honda S, et al. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects. Blood 2003;101:3485-3491 (Pubitemid 36857931)
27. Goodall AH, Appleby J. Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol 2004;272:225-253
28. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-315 (Pubitemid 17111279)
29. Lanza F, Stierle A, Fournier D, et al. A new variant of Glanzmann's thrombasthenia (Strasbourg I). Platelets with functionally defective glycoprotein IIb-IIIa complexes and a glycoprotein IIIa 214Arg-214Trp mutation. J Clin Invest 1992;89:1995-2004
30. Bierling P, Fromont P, Elbez A, Duedari N, Kieffer N. Early immunization against platelet glycoprotein IIIa in a newborn Glanzmann type I patient. Vox Sang 1988;55:109-113 (Pubitemid 18210944)
31. Male C, Koren D, Eichelberger B, Kaufmann K, Panzer S. Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography. Vox Sang 2006;91:174-177 (Pubitemid 44126614)
32. Giannini S, Mezzasoma AM, Guglielmini G, Rossi R, Falcinelli E, Gresele P. A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry. Cytometry B Clin Cytom 2008;74:194-199 (Pubitemid 351656300)
33. Vijapurkar M, Ghosh K, Shetty S, McLane MA, Moura da Silva AM, Butera D. A simple, novel and robust test to diagnose type I Glanzmann thrombasthenia. Haematologica 2008;93:797-798 (Pubitemid 351669327)
34. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard- Soulier syndrome. Blood 2002;100:2102-2107 (Pubitemid 35001244)
35. Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992;79:439-446
36. Vettore S, Scandellari R, Moro S, et al. Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica 2008;93:1743-1747
37. Giannini S, Mezzasoma AM, Leone M, Gresele P. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. Haematologica 2007;92:1647-1654 (Pubitemid 350248244)
38. Kunicki TJ, Johnson MM, Aster RH. Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome. J Clin Invest 1978;62:716-719
39. Visentin GP, Wolfmeyer K, Newman PJ, Aster RH. Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion 1990;30:694-700 (Pubitemid 20361783)
40. van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf 2004;27:1243-1252
41. Nurden AT, Nurden P, Bermejo E, Combrie R, McVicar DW, Washington AV. Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1. Thromb Haemost 2008;100:45-51 (Pubitemid 351948744)
42. Drouin A, Favier R, Masse JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001;98:1382-1391
43. Diamandis M, Paterson AD, Rommens JM, et al. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood 2008; November 6 (Epub ahead of print)
44. Diamandis M, Veljkovic DK, Maurer-Spurej E, Rivard GE, Hayward CP. Quebec platelet disorder: features, pathogenesis and treatment. Blood Coagul Fibrinolysis 2008;19: 109-119 (Pubitemid 351252988)
45. Noris P, Guidetti GF, Conti V, et al. Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia. Thromb Haemost 2006;95:483-489
46. Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007;139:363-372 (Pubitemid 47515353)
47. Dunkley S, Arthur JF, Evans S, Gardiner EE, Shen Y, Andrews RK. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway. Br J Haematol 2007;137:569-577 (Pubitemid 46817336)
48. Holzhauer S, Sitaru AG, Ebell W, et al. Decreased platelet reactivity identified by whole blood flow cytometry in Fanconi anaemia patients. Thromb Haemost 2007;98:1291-1297 (Pubitemid 350239101)
49. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008
50. Seidl C, Siehl J, Ganser A, et al. Platelet glycoprotein expression in patients with myelodysplastic syndrome. Thromb Res 2000;100:27-34 (Pubitemid 30797999)
51. Izumi M, Takeshita A, Shinjo K, et al. Decreased amount of mpl and reduced expression of glycoprotein IIb/IIIa and glycoprotein Ib on platelets from patients with refractory anemia: analysis by a non-isotopic quantitative ligand binding assay and immunofluorescence. Eur J Haematol 2001;66:245-252 (Pubitemid 32436739)
52. Senzel L, Gnatenko DV, Bahou WF. Genomic and proteomic applications in diagnosis of platelet disorders and classification. Semin Thromb Hemost 2008;34:532-538
53. Curtis BR. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost 2008;34:539-548
54. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res 2005;4:1516-1521
55. Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007;5:1945-1955 (Pubitemid 47288954)
56. Maurer-Spurej E, Kahr WH, Carter CJ, Pittendreigh C, Cameron M, Cyr TD. The value of proteomics for the diagnosis of a platelet-related bleeding disorder. Platelets 2008;19:342-351